Jian Xin Chen
Director Técnico/Científico/I+D en BIOMICS BIOPHARMA LTD .
Perfil
Jian Xin Chen is currently the Chief Technology Officer & Vice President at Biomics Biotechnologies Co., Ltd.
and the Chief Technology Officer at Biomics Biopharma Ltd.
Prior to his current positions, he worked as a Principal at Arbutus Biopharma Corp.
and Alnylam Pharmaceuticals, Inc. Chen received his undergraduate degree from Wuhan University, his doctorate from the University of British Columbia in 1991, and his graduate degree from the Chinese Academy of Sciences in 1984.
Cargos activos de Jian Xin Chen
| Empresas | Cargo | Inicio |
|---|---|---|
| BIOMICS BIOPHARMA LTD | Director Técnico/Científico/I+D | 01/01/2011 |
Biomics Biotechnologies Co., Ltd.
 Biomics Biotechnologies Co., Ltd. BiotechnologyHealth Technology Biomics Biotechnologies Co., Ltd. develops ribonucleic acid interference based treatment products. Its products offer treatments for Age-related Macular Degeneration (AMD), Hepatitis B, bladder cancer, and other diseases. The company was founded by York Yuan Zhu on February 17, 2006 and is headquartered in Nantong, China. | Director Técnico/Científico/I+D | 01/01/2011 |
Antiguos cargos conocidos de Jian Xin Chen.
| Empresas | Cargo | Fin |
|---|---|---|
| ARBUTUS BIOPHARMA CORPORATION | Corporate Officer/Principal | - |
| ALNYLAM PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Formación de Jian Xin Chen.
| University of British Columbia | Doctorate Degree |
| Chinese Academy of Sciences | Graduate Degree |
| Wuhan University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | Health Technology |
| ARBUTUS BIOPHARMA CORPORATION | Health Technology |
| BIOMICS BIOPHARMA LTD | Process Industries |
| Empresas privadas | 1 |
|---|---|
Biomics Biotechnologies Co., Ltd.
Biomics Biotechnologies Co., Ltd. BiotechnologyHealth Technology Biomics Biotechnologies Co., Ltd. develops ribonucleic acid interference based treatment products. Its products offer treatments for Age-related Macular Degeneration (AMD), Hepatitis B, bladder cancer, and other diseases. The company was founded by York Yuan Zhu on February 17, 2006 and is headquartered in Nantong, China. | Health Technology |
- Bolsa de valores
- Insiders
- Jian Xin Chen